Ovid Therapeutics (OVID) Price to Sales (2021 - 2026)
Ovid Therapeutics' (OVID) Price to Sales came in at 313.96 for Q2 2026, compared with 3.53 a year earlier and up 639.7% from the prior quarter.
Powered by 
Analysis
Ovid Therapeutics (OVID) Price to Sales (2021 - 2026) Analysis & Trends
For FY2025, Ovid Therapeutics' Price to Sales stood at 16.57, down 85.8% from FY2024.
- In prior years, Ovid Therapeutics' Price to Sales was 116.68 in FY2024 (-79.9%), 580.68 in FY2023 (+565.8%), 87.22 in FY2022 and 1.08 in FY2021 (-91.0%).
- The Q2 2026 figure stands as the highest quarterly Price to Sales since Q1 2024.
- On a year-over-year basis, Price to Sales increased in 1 of the last seven quarters, with an average decline of 74.7%.
- The strongest year-over-year quarter for Price to Sales in the past five years was Q3 2023, with growth of 929.0%; the weakest was Q2 2025, with a decline of 96.3%.
- According to Business Quant data, Price to Sales for the three prior quarters was 42.45 (Q1 2026), 16.57 (Q4 2025) and 13.99 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Ovid Therapeutics | 439.72 Mn | 71.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 313.96 |
| Mar 31, 2026 | 42.45 |
| Dec 31, 2025 | 16.57 |
| Sep 30, 2025 | 13.99 |
| Jun 30, 2025 | 3.53 |
| Mar 31, 2025 | 40.23 |
| Dec 31, 2024 | 116.68 |
| Sep 30, 2024 | 132.58 |
| Jun 30, 2024 | 96.21 |
| Mar 31, 2024 | 455.47 |
| Dec 31, 2023 | 580.68 |
| Sep 30, 2023 | 916.07 |
| Jun 30, 2023 | 1,167.33 |
| Mar 31, 2023 | 1,474.02 |
| Dec 31, 2022 | 87.22 |
| Sep 30, 2022 | 89.02 |
| Jun 30, 2022 | 104.75 |
| Mar 31, 2022 | 152.98 |
| Dec 31, 2021 | 1.08 |
| Sep 30, 2021 | 1.07 |
API Access
Ovid Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();